Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany

A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24–59 months of age

(2013) Seth L. Toback et al.   VACCINE

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing

(2012) C. S. Ambrose et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years

(2011) Christopher S. Ambrose et al.   Influenza and Other Respiratory Viruses

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies

(2011) Christopher S. Ambrose et al.   VACCINE

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age

(2010) Robert B. Belshe et al.   Influenza and Other Respiratory Viruses

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

(2010) Christopher S. Ambrose et al.   Influenza and Other Respiratory Viruses

Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines

(2009) Arnold S. Monto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials

(2008) Janelle Rhorer et al.   VACCINE